Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 14, 2006; 12(22): 3481-3486
Published online Jun 14, 2006. doi: 10.3748/wjg.v12.i22.3481
Published online Jun 14, 2006. doi: 10.3748/wjg.v12.i22.3481
GO1 annotation/ Gene name | Gene accession | GO accession | Small2 | Large3 | Ratio (L/S) |
Immune response | GO:0006955 | ||||
CD1d1 antigen | NM_007639 | 107 | 156 | 1.46 | |
CD1d2 antigen | NM_007640 | 80 | 131 | 1.64 | |
CD86 antigen; B7-2; CD28 antigen ligand 2 (CD28L2) | L25606 | 52 | 17 | 0.33 | |
Histocompatibility 2, class II antigen E alpha | NM_010381 | 132 | 407 | 3.08 | |
Histocompatibility 2, class II antigen A, beta 1 | NM_010379 | 586 | 832 | 1.42 | |
Histocompatibility 2, class II antigen E beta | NM_010382 | 3579 | 4481 | 1.25 | |
Interleukin 2 receptor, beta chain | NM_008368 | 540 | 2604 | 4.83 | |
Cell adhesion | GO:0007155 | ||||
Intercellular adhesion molecule 1 (ICAM1) | X52264 | 39 | 20 | 0.51 | |
Vascular cell adhesion molecule 1 (VCAM1) | M84487 | 17 | 11 | 0.65 | |
Cadherin 1 (CDH1); epithelial cadherin (E-cadherin; E-CAD); uvomorulin (UM) | X06115 | 32 | 42 | 1.29 | |
Cytoskeleton | GO:0005856 | ||||
Cytoplasmic beta-actin (ACTB) | M12481 | 455 | 275 | 0.60 | |
Vimentin (VIM) | X51438 | 260 | 73 | 0.28 | |
Proteolysis | GO:0006508 | ||||
Matrix metalloproteinase 14 (MMP14); membrane-type matrix matalloproteinase 1 (MTMMP1) | X83536 | 2585 | 1339 | 0.52 | |
Cell death | GO:0008219 | ||||
Fas antigen ligand (FASL); apoptosis antigen ligand (APTL; APT1LG1); tumor necrosis factor superfamily member 6 (TNFSF6); generalized lymphoproliferative disease protein (GLD) | U06948 | 37 | 21 | 0.57 | |
Fas antigen; fasL receptor; apoptosis antigen 1 (APO1; APT1); CD95 antigen | M83649 | 18 | 20 | 1.07 | |
Fas death domain-associated protein | NM_007829 | 392 | 103 | 0.26 | |
Fas-associating protein with death domain | NM_010175 | 484 | 188 | 0.39 | |
B-cell leukemia/lymphoma protein 2 (BCL2) | M16506 | 31 | 18 | 0.56 | |
Caspase 9 | NM_015733 | 318 | 996 | 3.14 | |
Anti-apoptosis | |||||
Insulin-like growth factor 1 receptor alpha subunit (IGFIR-alpha) | U00182 | GO:0006916 | 95 | 176 | 1.86 |
Inflammatory response | GO:0006954 | ||||
Tumor necrosis factor | NM_013693 | 130 | 275 | 2.11 | |
Tumor necrosis factor (ligand) superfamily, member 4 | NM_009452 | 98 | 227 | 2.32 | |
Tumor necrosis factor (ligand) superfamily, member 7 | NM_011617 | 133 | 239 | 1.80 | |
Tumor necrosis factor (ligand) superfamily, member 8 | NM_009403 | 189 | 514 | 2.73 | |
Tumor necrosis factor (ligand) superfamily, member 9 | NM_009404 | 278 | 305 | 1.10 | |
Tumor necrosis factor (ligand) superfamily, member 19 | NM_011615 | 164 | 88 | 0.53 | |
Tumor necrosis factor receptor superfamily member 1A (TNFRSF1A); tumor necrosis factor receptor 1 (TNFR1) | X57796 | 58 | 41 | 0.72 | |
Tumor necrosis factor receptor superfamily member 1B2 (TNFRSF1B2); tumor necrosis factor receptor 2 (TNFR2) | M59378 | 18 | 17 | 0.92 | |
Interleukin 6 receptor alpha subunit (IL6R-alpha; IL6RA) | X51975 | 57 | 64 | 1.13 | |
Cytokine activity | GO:0005125 | ||||
Interleukin 6 (IL6) | X06203 | 36 | 25 | 0.70 | |
Oncostatin M (OSM) | D31942 | 79 | 509 | 6.42 | |
Cellular metabolism | GO:0044237 | ||||
PDC-E2 | NT | NT | |||
PDC-E3BP | NT | NT | |||
Transport | GO:0006810 | ||||
Solute carrier family 4 (anion exchanger), member 2 | NM_009207 | 80 | 145 | 1.82 | |
Solute carrier family 4 (anion exchanger), member 3 | NM_009208 | 52 | 120 | 2.31 | |
Solute carrier family 4 (anion exchanger), member 1 | NM_011403 | 995 | 2146 | 2.16 | |
Voltage-dependent anion channel 1 | NM_011694 | 111 | 146 | 1.32 | |
Voltage-dependent anion channel 2 | NM_011695 | 87 | 62 | 0.71 | |
Solute carrier family (organic anion transporter) member 1 | NM_013797 | 76 | 114 | 1.50 | |
Aquaporin 1 | NM_007472 | 257 | 245 | 0.95 | |
Aquaporin 2 | NM_009699 | 198 | 276 | 1.39 | |
Aquaporin 3 | NM_016689 | 124 | 204 | 1.64 | |
Aquaporin 5 | NM_009701 | 396 | 222 | 0.56 | |
Aquaporin 8 | NM_007474 | 2160 | 8728 | 4.04 | |
Solute carrier family 10 (sodium/bile acid cotransporter family), member 1 | NM_011387 | 208 | 402 | 1.93 | |
G-protein coupled purinergic receptor P2Y1 (P2RY1) | U22829 | 346 | 652 | 1.89 | |
Purinergic receptor P2X, ligand-gated ion channel 4 | NM_011026 | 711 | 2229 | 3.13 | |
Detection of Stimulus | GO0051606 | ||||
Toll-like receptor 2 | NM_011905 | 95 | 68 | 0.72 | |
Toll-like receptor 5 | NM_016928 | 168 | 114 | 0.68 | |
Toll-like receptor 6 | NM_011604 | 255 | 569 | 2.23 | |
Cell proliferation | GO:0008283 | ||||
FMS-like tyrosine kinase 1 (FLT1); vascular endothelial growth factor receptor 1 (VEGFR1) | L07297 | 36 | 23 | 0.65 | |
Epidermal growth factor (EGF) | J00380 | 88 | 116 | 1.32 | |
Kinase insert domain receptor (KDR); vascular endothelial growth factor receptor 2 (VEGFR2); FLK1 | X70842 | 93 | 58 | 0.62 | |
Vascular endothelial growth factor (VEGF); vascular permeability factor (VPF) | M95200 | 165 | 152 | 0.92 | |
Heparin-binding growth factor 5 (HBGF5); fibroblast growth factor 5 (FGF5) | M30643 | 355 | 152 | 0.43 | |
Fibroblast growth factor receptor 3 (FGFR3); heparin-binding growth factor receptor (HBGFR) | M81342 | 192 | 485 | 2.53 | |
Transforming growth factor beta 1 (TGF-beta 1; TGFB1) | M13177 | 69 | 105 | 1.51 | |
Transforming growth factor beta receptor 1 (TGF-beta receptor 1; TGFR1); ESK2 | D25540 | 44 | 29 | 0.65 | |
Acetylcholine receptor M3 | NM_033269 | NT | NT | ||
Cell cycle | GO:0007049 | ||||
Proliferating cell nuclear antigen (PCNA); cyclin | X53068 | 211 | 124 | 0.59 | |
Cell growth | |||||
Estrogen receptor 1 (ESTR1); estrogen receptor alpha (ER-alpha; ESTRA) | M38651 | GO:0016049 | 22 | 33 | 1.48 |
Others | |||||
Nerve growth factor receptor | AF105292 | GO:0007411 | N.T. | N.T. | |
Neurotrophic tyrosine kinase receptor type1 | XM283871 | GO:0042490 | N.T. | N.T. | |
Neurotrophic tyrosine kinase receptor type 2 | M33385 | GO:0042490 | 93 | 18 | 0.20 |
Neurotrophic tyrosine kinase, receptor, type 3 | NM_008746 | GO:0042490 | 2923 | 3827 | 1.31 |
Interferon gamma receptor (IFN-gamma receptor; IFNGR) | M28233 | GO:0005615 | 51 | 50 | 0.98 |
- Citation: Fukushima K, Ueno Y. Bioinformatic approach for understanding the heterogeneity of cholangiocytes. World J Gastroenterol 2006; 12(22): 3481-3486
- URL: https://www.wjgnet.com/1007-9327/full/v12/i22/3481.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i22.3481